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Abstract
Introduction: To the best of our knowledge, this is the first report in the literature of development of neurogenic
diabetes insipidus in a patient with subacute liver failure.
Case presentation: A 25-year-old man presented with subacute liver failure. While awaiting a liver transplant, the
patient developed cerebral edema, which resulted in neurogenic diabetes insipidus secondary to cerebral edema.
The patient died before the liver transplantation could be carried out.
Conclusion: Neurogenic diabetes insipidus is well recognized in the neurosurgical population as a consequence of
cerebral edema and increased intracranial pressure, both of which occur commonly in patients with subacute liver
failure.
Introduction
Cerebral edema occurs in patients presenting with ful-
minant liver failure, resulting in increased intracranial
pressure (ICP). The incidence and severity of cerebral
edema increases as the onset of liver failure becomes
rapid. It occurs in up to 80% of patients with acute and
hyperacute fulminant liver failure but less frequently
(20%) in those with subacute fulminant liver failure.
There is a significant association between the presence
of cerebral edema and the development of central dia-
betes insipidus in patients with traumatic brain injury
[1] and in postoperative neurosurgical patients. We pre-
sent a case of neurogenic diabetes insipidus that devel-
oped during the course of subacute fulminant liver
failure.
Case presentation
A 25-year-old Nigerian man was admitted to our hospi-
tal’s intensive care unit (ICU), after emergency tracheal
intubation and ventilation for worsening encephalopathy
and a deteriorating Glasgow Coma Scale score. The
working diagnosis was seronegative hepatitis leading to
subacute fulminant liver failure and grade three hepatic
encephalopathy.
His admission to our hospital was preceded by an
admission to a local hospital with a ten day history of
painless jaundice and malaise, progressing to three days
of nausea and vomiting. The patient had no history of
encephalopathy or coagulopathy. Liver function tests on
admission were abnormal (bilirubin, 381 μmol/L, alanine
transferase [ALT], 684 U/L), but an ultrasound scan
showed a normal liver. Autoimmune and viral screen
results were negative except for anti-smooth muscle
antibody, which was 1 in 40 dilutions. He was sickle cell
negative, and virology screening results were also nega-
tive. He had coagulopathy with an International Nor-
malized Ratio (INR) above ten, which responded to
vitamin K and fresh-frozen plasma (FFP). The patient
had no history of any recent foreign travel, intravenous
(IV) drug use, excessive alcohol intake or any family his-
tory of liver or autoimmune disease. The patient was
discharged home five days after admission with plans
for outpatient follow-up.
Six weeks after the initial presentation, the patient was
readmitted to the same local hospital with continuing
malaise, reduced appetite, vomiting, abdominal pain,
worsening jaundice and confusion. The liver function
tests on this occasion were bilirubin, 597; ALT, 475;
alkaline phosphatase (ALP), 859; albumin, nine; and INR
above nine. Results of blood films for malaria were
negative. The patient was intubated and ventilated in
the ICU before being transferred to our hospital on
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three weeks after this admission. He was found to have
grade three hepatic encephalopathy. A repeat ultrasound
scan of his abdomen revealed mild hepatosplenomegaly.
A computed tomography (CT) scan of his head before
transfer was normal, and CT scans of his thorax and
abdomen showed a normal-looking liver, splenomegaly
and coeliac lymphadenopathy.
On admission to our ICU, the patient was hemodyna-
mically stable and was ventilated on pressure-controlled
synchronized intermittent mandatory ventilation
(PCSIMV) to achieve normocapnia (PaCO2, 4.0-4.5
kPa). His urea and creatinine levels at admission were
2.8 mmol/L and 112 μmol/L, respectively. His INR was
4.4 after correction with FFP and vitamin K. Paraceta-
mol levels were undetectable, and the serum lactate
level was normal.
The patient was diagnosed with seronegative (virology
screen negative) subacute (jaundice and encephalopathy
> eight weeks) fulminant liver failure, such that he was
listed for urgent liver transplantation as the satisfied the
King’s College criteria for transplantation in acute liver
failure unrelated to paracetamol overdose [2].
After the patient was listed for urgent liver transplant,
a retrograde jugular bulb catheter was inserted into the
patient to monitor his jugular venous oxygen saturation
and to optimize cerebral perfusion management. His
jugular venous saturation was 91%, suggesting cerebral
hyperemia. The management as per our ICU protocol
included mild hypothermia (35°C), deep IV sedation and
mean arterial pressure of below 85 mm Hg. This
reduced his SjvO2 to 73%, which was followed by a sus-
tained increase of more than 85%. The patient’s serum
ammonia level at this time was 170 μmol/L (reference
range, 10-50 μmol/L). In keeping with our standard
practice for the management of acute liver failure, an
extradural Camino ICP bolt was inserted to monitor his
ICP. The opening ICP was 15 mm Hg, which settled at
8 9 mm Hg with conservative management using a clear
pressure waveform.
Over the next 24 hours, the patient became progres-
sively polyuric, with a urine output ranging between 300
and 450 mL/h. He had not received mannitol or other
diuretics during his admission to the ICU. His serum
sodium level increased to 168 mmol/L, and his urea and
glucose levels were at 3 mmol/L and 3.6 mol/L, respec-
tively. His paired measured plasma was 368 mOsmol/L
and urine osmolalities were 175 mOsmol/L. The poly-
uria was initially treated with water via nasogastric tube
and with IV electrolyte-free solutions. A diagnosis of
central diabetes insipidus was then made. Nephrogenic
diabetes insipidus was excluded because of the absence
of drugs known to cause it (the patient was being given
piperacillin/tazobactam [Tazocin], fluconazole, panto-
prazole and lactulose), normal blood levels of potassium
and calcium ions, and the resolution of polyuria in
response to desmopressin therapy.
Approximately 24 hours after the onset of neurogenic
diabetes insipidus, the patient’s pupils became progres-
sively more dilated and unreactive to light. His ICP,
however, remained stable at 15 mm Hg. After a bolus of
mannitol (0.5 g/kg), the patient was transferred to the
radiology suite. A CT brain scan revealed a relatively
tight supratentorial compartment with evidence of
edema but with a minimal change in his infratentorial
compartment and widely patent prepontine ambient
cisterns. No acute bleed was identified (Figures 1 and 2).
A neurology consultation was sought because the
patient now had neurogenic diabetes insipidus, fixed
dilated pupils and supratentorial cerebral edema with
maximal therapy, normal ICP, and no surgically treata-
ble intracranial pathology on a background of subacute
fulminant liver failure. The neurology opinion was that
the patient had most likely experienced an irreversible
transtentorial brain herniation despite an apparently
normal ICP; thus, the likelihood of favorable neurologic
recovery was minimal. A joint decision with the trans-
plant team was then made to remove the patient from
the transplant list. The patient died approximately
24 hours later.
Postmortem examination revealed “mild” cerebral
edema with the presence of Alzheimer-type II astro-
cytes, suggesting hepatic encephalopathy. Histologic
examination of the liver confirmed acute massive con-
fluent hepatic necrosis with no evidence of chronic liver
disease, possibly suggestive of an autoimmune etiology.
Discussion
Hepatic encephalopathy in patients with fulminant liver
failure is characterized by changes in cerebral blood
flow, cerebral edema and intracranial hypertension. Cer-
ebral blood flow may increase in patients with fulminant
hepatic failure because of gradual cerebral arteriolar
vasodilatation and may lead to cerebral hyperemia and
jugular venous oxygen saturations above 75% [3]. The
prognosis for patients with such cerebral “luxury perfu-
sion” and cerebral edema is very poor [4].
Cerebral edema in patients with fulminant liver failure
is a characteristically cytotoxic edema resulting primarily
from astrocyte swelling. This was demonstrated in our
patient during the postmortem examination [5].
Increased ICP associated with cerebral edema is a com-
mon complication of fulminant liver failure. Clinical
signs of cerebral edema and intracranial hypertension in
patients with metabolic encephalopathy are neither spe-
cific nor sensitive. Features commonly seen are pupillary
abnormalities, exaggerated reflexes and hemodynamic
instability. A head CT scan frequently demonstrates
cerebral edema in acute liver failure patients with
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advanced-stage hepatic encephalopathy [6] but is insen-
sitive to intracranial hypertension [7]. In addition,
clinical signs of intracranial hypertension, such as
decerebrate posturing and sluggish pupillary responses,
have been seen at ICPs of only 15 to 16 mm Hg in
patients with fulminant hepatic failure and cerebral
edema [7].
Neurogenic diabetes insipidus is an uncommon condi-
tion. It is usually caused by lesions in the pituitary or
supraoptic gland and paraventricular nuclei. It has also
been identified in a variety of conditions. Neurogenic
diabetes insipidus is defined as a decreased secretion of
arginine vasopressin (AVP) leading to a high urine out-
put of greater than 30 mL/kg per 24 hours [4]. For
polyuria to become clinically apparent, 80% of AVP-
secreting neurons must be destroyed. The pathophysio-
logy of posttraumatic neurogenic diabetes insipidus may
involve increased ICP and cerebral edema around the
hypothalamus or posterior pituitary gland, which
explains the occurrence of diabetes insipidus in our
patient [1].
Conclusions
To the best of our knowledge, there are no reports in
the literature of neurogenic diabetes insipidus associated
with cerebral edema from fulminant liver failure. Our
patient had evidence of metabolic encephalopathy, cere-
bral hyperemia and cerebral edema. The cerebral edema
Figure 1 Computed tomography image showing significant edema predominantly in the supratentorial region.
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had a relatively supratentorial distribution. The anatomi-
cal proximity of edema to the neurohypophysis most
likely resulted in neurogenic diabetes insipidus.
Consent
Written informed consent could not be obtained despite
all reasonable attempts as next of kin could not be con-
tacted. Every effort has been made to protect the identity
of the patient and there is no reason to think that the
patient or their family would object to this publication.
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Figure 2 Computed tomography image showing relative sparing of the infratentorial compartment.
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